black box warning for glp 1 agonists The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Advances in incretin therapies for

Researchers also study TB-500 , a synthetic peptide based on the active region of the naturally occurring actin-binding protein thymosin beta-4

Other ingredients Caprylic/capric triglyceride, curcuma longa (turmeric) root extract, avena sativa (oat) kernel extract, simmondsia chinensis (jojoba) seed oil, acetyl hexapeptide-8, capryloyl salicylic acid, lavandula angustifolia (lavender) oil, lavandula hybrida oil, anthemis nobilis flower oil, boswellia carterii oil, cocos nucifera (coconut) oil, persea gratissima (avocado) oil, silica, fragrance, oryza sativa (rice) bran extract, rosmarinus officinalis (rosemary) leaf extract, helianthus annuus (sunflower) extract, tocopherol

Stern Warning: Experimenting with neuroactive substances can have unpredictable and lasting effects on your mental health

It works, but its messy